FDA approves Anacor's first drug, Kerydin, for onychomycosis

By Michael FitzhughStaff Writer

Tuesday, July 8, 2014

Anacor Pharmaceuticals Inc. on Tuesday won earlier-than-expected FDA approval for its first drug, Kerydin (tavaborole), a topical antifungal for the treatment of the common toenail and nail bed infection onychomycosis.